QA: RVL Pharmaceuticals plc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001739426_2021_RVL_Pharmaceuticals_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001739426, RVL Pharmaceuticals plc

  xvar xval
0 AssetsCurrent 173,154,000
1 IntangibleAssetsNetIncludingGoodwill 166,613,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 31,182,000
4 LiabilitiesCurrent 55,784,000
5 LiabilitiesNoncurrent 220,961,000
6 remainder_Liabilities 348,000
7 CostOfGoodsAndServicesSold 74,480,000
8 SellingGeneralAndAdministrativeExpense 81,961,000
9 ResearchAndDevelopmentExpense 19,696,000
10 remainder_Expenses 67,486,000
11 remainder_Revenues 177,884,000
12 remainder_NetIncome -13,850,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 370,949,000
1 Liabilities 277,093,000
2 Expenses 243,623,000
3 Revenues 177,884,000
4 StockholdersEquity 93,856,000
5 NetIncome -79,589,000
6 ComprehensiveNetIncome -79,589,000
7 BaseVar 541,699,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.386
9 EconomicCapitalRatio 1.78

Edgar->Model Mapping

Feature Distribution

Change over Time